While the added sensitivity of titin brings potential advantages towards evaluating therapeutic efficacy, since it is also a muscle-specific protein, similar to CK, it is also likely to decrease with age and the corresponding muscle loss in DMD [23, 37]. The gene discussed is TTN; the disease is Duchenne muscular dystrophy.